» Articles » PMID: 30899434

Aurora A Inhibition Limits Centrosome Clustering and Promotes Mitotic Catastrophe in Cells with Supernumerary Centrosomes

Overview
Journal Oncotarget
Specialty Oncology
Date 2019 Mar 23
PMID 30899434
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of supernumerary centrosomes is prevalent in cancer, where they promote the formation of transient multipolar mitotic spindles. Active clustering of supernumerary centrosomes enables the formation of a functional bipolar spindle that is competent to complete a bipolar division. Disruption of spindle pole clustering in cancer cells promotes multipolar division and generation of non-proliferative daughter cells with compromised viability. Hence molecular pathways required for spindle pole clustering in cells with supernumerary centrosomes, but dispensable in normal cells, are promising therapeutic targets. Here we demonstrate that Aurora A kinase activity is required for spindle pole clustering in cells with extra centrosomes. While cells with two centrosomes are ultimately able to build a bipolar spindle and proceed through a normal cell division in the presence of Aurora A inhibition, cells with supernumerary centrosomes form multipolar and disorganized spindles that are not competent for chromosome segregation. Instead, following a prolonged mitosis, these cells experience catastrophic divisions that result in grossly aneuploid, and non-proliferative daughter cells. Aurora A inhibition in a panel of Acute Myeloid Leukemia cancer cells has a similarly disparate impact on cells with supernumerary centrosomes, suggesting that centrosome number and spindle polarity may serve as predictive biomarkers for response to therapeutic approaches that target Aurora A kinase function.

Citing Articles

Centrosome amplification primes ovarian cancer cells for apoptosis and potentiates the response to chemotherapy.

Edwards F, Fantozzi G, Simon A, Morretton J, Herbette A, Tijhuis A PLoS Biol. 2024; 22(9):e3002759.

PMID: 39236086 PMC: 11441705. DOI: 10.1371/journal.pbio.3002759.


Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer.

Polverino F, Mastrangelo A, Guarguaglini G Cells. 2024; 13(16).

PMID: 39195284 PMC: 11353082. DOI: 10.3390/cells13161397.


Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction.

Kalkan B, Ozcan S, Cicek E, Gonen M, Acilan C Cell Death Dis. 2024; 15(3):222.

PMID: 38493150 PMC: 10944510. DOI: 10.1038/s41419-024-06601-0.


Cortical dynein drives centrosome clustering in cells with centrosome amplification.

Mercadante D, Aaron W, Olson S, Manning A Mol Biol Cell. 2023; 34(6):ar63.

PMID: 37017483 PMC: 10208098. DOI: 10.1091/mbc.E22-07-0296.


Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.

Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D Cell Death Differ. 2023; 30(5):1305-1319.

PMID: 36864125 PMC: 10154422. DOI: 10.1038/s41418-023-01140-1.


References
1.
Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y . Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 1999; 59(9):2041-4. View

2.
Giet R, Uzbekov R, Cubizolles F, Le Guellec K, Prigent C . The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5. J Biol Chem. 1999; 274(21):15005-13. DOI: 10.1074/jbc.274.21.15005. View

3.
Brinkley B . Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 2001; 11(1):18-21. DOI: 10.1016/s0962-8924(00)01872-9. View

4.
Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K . Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer. 2001; 84(6):824-31. PMC: 2363814. DOI: 10.1054/bjoc.2000.1684. View

5.
Nigg E . Centrosome aberrations: cause or consequence of cancer progression?. Nat Rev Cancer. 2002; 2(11):815-25. DOI: 10.1038/nrc924. View